DOCSLIB.ORG

Neuroimmunology: to Sense and Protect Eugene M

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neuroimmunology: to Sense and Protect Eugene M Neuroimmunology: To Sense and Protect Eugene M. Oltz J Immunol 2020; 204:239-240; ; This information is current as doi: 10.4049/jimmunol.1990024 of September 24, 2021. http://www.jimmunol.org/content/204/2/239 Downloaded from References This article cites 11 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/204/2/239.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 24, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2020 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Neuroimmunology: To Sense and Protect he influence of the CNS and peripheral nervous system (PNS) on immune health, and vice versa, has T been a central theme of health, science, and folklore for centuries. People have long suspected that stress en- hances our susceptibility to infections and promotes episodes of autoimmunity. On the flip side, Cox2 inhibitors amelio- rate both immune-based inflammation and neural-based pain. Clinicians also noted that denervation can stem the progres- sion of rheumatoid arthritis or psoriasis, suggesting that sen- sory neurons might fuel some aspects of inflammation. However, cross-talk between the neural and immune sys- Downloaded from tems, which are so central to human health and disease, was difficult to assess and, until recently, neuroimmunology was relegated to the final sessions of many conferences. This backwater status has taken a dramatic about-face in recent years because of a number of watershed discoveries. These include our realization that Alzheimer disease (AD) and other neurode- Confocal micrograph showcasing meningeal lymphatic vessels along the http://www.jimmunol.org/ generative conditions are propagated by inflammation, with some superior sagittal sinus using tdTomato driven by the Prox1 promoter, of the neuronal destruction occurring through actions of immune shown in yellow. Macrophages are stained with Iba1 in magenta, and cells within the CNS. T cells are shown in cyan using CD3 as a marker. Iba1-positive cells are spread throughout the meningeal whole mount, whereas CD3-positive As with many revolutions, the emergence of neuro- T cells are frequently found in close association with lymphatic vessels immunology as a prominent field came with technical as well as distributed throughout the meninges. Image provided by advances that now permit a more holistic approach to study Jonathan Kipnis, University of Virginia. dialogue between the immune system and other organ systems. Breakthroughs in multiparameter cytometry, imaging, and by guest on September 24, 2021 single-cell sequencing technologies have begun to unravel, two systems, which they call the “neuroimmune interactome.” with an unprecedented resolution, the diversity of cells, their Next, Kaplan and colleagues (2) delve into a more specific locations, and molecular functions that orchestrate the immune– aspect of neuroimmune cross-talk: neuronal regulation of neural interface. cutaneous immunity. As discussedinbothreviews,thePNS Given the palpable excitement and the rapid proliferation of and immune systems serve as sentinels for invading patho- papers in the field, I felt that it would be timely for the fourth gens, with barrier tissues, such as the skin, being rich in annual issue of topical reviews to focus on neuroimmunology. immune cells and nociceptors, sensory neurons that detect I am proud to introduce “Neuroimmunology: To Sense and noxious agents or dangerous pathogens by producing pain Protect”—a collection of 11 reviews, including a Translating or itch sensations. Both the Woolf and Kaplan reviews high- Immunology review and a Pillars of Immunology commentary. light the multitude of molecules produced by neurons and It is my hope that this collection will provide our readers with immune cells to communicate danger to each other (e.g., a broad perspective on not only the healthy dialogue be- cytokines, chemokines, and neuropeptides) and by which tween immune and neural cells, which maintains homeo- neurons can sense pathogens (e.g., TLRs). stasis in both systems, but also how the wrong conversations Henneke and colleagues (3) next discuss how immune cells or overreaction of one system can trigger a variety of patho- communicate with the PNS to discriminate between healthy logical conditions, ranging from chronic pain to autoimmu- and damaged neurons. The authors discuss the variety of em- nity to loss of neural function. bryonically derived macrophages that associate with peripheral The first portion of this special collection focuses on the neurons. These cells not only may contribute to axon guidance, interplay between the immune system and the PNS. Woolf homeostasis, and nerve regeneration but also can cause damage and colleagues (1) begin the collection with an overview of following an infection or trauma. The codependent mecha- the plasticity present in both systems, highlighting the “sense nisms may be especially relevant to peripheral nerve diseases, and protect” theme. They also provide a thoughtful discussion including diabetic neuropathy and chronic pain. of how to prioritize approaches that will yield a deeper un- Another emerging theme in neuroimmunology is the im- derstanding of receptor–ligand communication between the portant role that neurons may play in in the tumor micro- environment. Shurin et al. (4) review how nerves, especially glial Schwann cells, can create tumor-friendly inflammatory Copyright Ó2020 by The American Association of Immunologists, Inc. 0022-1767/20/$37.50 microenvironments and can serve as “magnets” to promote www.jimmunol.org/cgi/doi/10.4049/jimmunol.1990024 240 EDITORIAL tumor migration (metastasis). Once the tumor is formed and autoimmune encephalomyelitis, the classic mouse model of innervated, neurons can generate immunosuppressive cytokine multiple sclerosis. The author describes the Th1/Th17 nature milieus and have a profound negative impact on therapeutic of experimental autoimmune encephalomyelitis and the responses. soluble factors that drive inflammatory responses, resulting The collection then shifts focus to the CNS, historically in myelin destruction. Karpus also discusses the opportu- thought to be devoid of lymphoid cells under healthy con- nities and challenges of targeting these cytokine culprits ditions due to their exclusion by the blood–brain barrier. with a new generation of therapeutics. Pierce and colleagues Recent breakthrough studies, however, indicate that immune (11) conclude with an update on the quest to understand cells do reside within the CNS, especially in the meninges cerebral malaria, a disease characterized by uncontrolled surrounding the parenchyma, and that special mechanisms immune responses to Plasmodium infections that can result are at play to enforce “immune privilege.” Kipnis and col- in long-term disabilities, especially in children. The authors leagues (5) review the current understanding of CNS immune describe exciting advances in a mouse model for cerebral structures and how cerebral spinal fluid likely serves as a malaria, and how this model will be employed in a search highway for the movement of CNS-derived Ags toward for therapeutic interventions. meningeal immune cells and into the peripheral immune Together, this collection will provide readers with a panoramic system. Although our current understanding of these ana- overview of leading-edge research on the complex conversations tomical connections is inchoate, progress in this area will have that transpire continuously between the nervous and immune broad implications for infectious disease, autoimmunity, and systems. Although the field of neuroimmunology has advanced Downloaded from immune responses to CNS tumors. in leaps and bounds, much work yet remains. New insights One of the sole immune cell types to reside in the pa- are especially imperative given the advancing age of our human renchyma is the microglia, a CNS-resident macrophage. In population, which will only escalate the prevalence of neuro- aselectedPillars of Immunology article and accompanying degenerative disorders with immune/inflammatory origins. Once commentary, Antel et al. (6) describe their pioneering again, immunologists will play a vital role this quest, as we work in culturing adult human microglia from healthy expand and strengthen our collaborative networks to include http://www.jimmunol.org/ primary tissues. This advance permitted the first charac- neuroscientists and neurologists. Only then will we understand terizations of microglial signatures at the molecular level how to control the neuroimmune dialogue, confining it to its and furthered the understanding of how microglia con- primary role: to sense and protect us from the harsh world in tribute to immune responses, clear debris, and communi- which we live. cate with astrocytes,
Load more

Recommended publications
  • Journal of Neuroimmunology
    JOURNAL OF NEUROIMMUNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.2 • Guide for Authors p.3 ISSN: 0165-5728 DESCRIPTION . The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication. Works pertaining to multiple sclerosis, AIDS, amyotrophic lateral sclerosis, Guillain Barré Syndrome, myasthenia gravis, and brain tumors form a major focus. The scope of the Journal is broad, covering both research and clinical problems of neuroscientific interest. A major aim of the Journal is to encourage the development of immunologic approaches to analyse in further depth the interactions and specific properties of nervous tissue elements during development and disease. AUDIENCE . Researchers in neurology, immunology, neuroscience, neuropathology, and experimental neurology IMPACT FACTOR . 2020: 3.478 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . BIOSIS Citation Index Chemical Abstracts Current Contents - Life Sciences Embase PubMed/Medline Pascal Francis Reference Update Scopus AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jneuroim 1 EDITORIAL BOARD . Editors-in-Chief Robyn Klein, Washington University in St Louis School of Medicine, Campus Box 8301660 S. Euclid Ave., MO 63110-1093, Saint Louis, Missouri, United States of America Laura Piccio, The University of Sydney Brain and Mind Centre, Camperdown, Australia Gregory Wu, Washington University in St Louis School of Medicine, Campus Box 8301660 S.
    [Show full text]
  • 2021 Psychiatry CC-MOC Content Specifications
    CONTINUING CERTIFICATION/MOC EXAMINATION IN PSYCHIATRY The American Board of Psychiatry and Neurology, Inc. (ABPN) has issued new, two- dimensional content specifications for the psychiatry, neurology and child neurology continuing certification/MOC examinations. Questions for the 2021 psychiatry, neurology and child neurology continuing certification examinations will conform to these new content specifications. Within the two-dimensional format, one dimension is comprised of disorders and topics while the other is comprised of competencies and mechanisms that cut across the various disorders of the first dimension. By design, the two dimensions are interrelated and not independent of each other. All of the questions on the examination will fall into one of the disorders/topics and will be aligned with a competency/mechanism. For example, an item on substance use could focus on treatment, or it could focus on systems-based practice. The psychiatry, neurology and child neurology continuing certification content specifications can be accessed from the Specialty MOC Exams section of our website. Candidates should use the new detailed content specifications as a guide to prepare for a continuing certification examination. Scores for these examinations will be reported in a standardized format rather than the previous percent correct format. In addition to these three continuing certification examinations, ABPN examinations will gradually conform to the new two-dimensional content specification starting in 2018. The American Board of Psychiatry and Neurology, Inc. is a not-for-profit corporation dedicated to serving the public interest and the professions of psychiatry and neurology by promoting excellence in practice through certification and continuing certification processes. For more information, please contact us at [email protected] or visit our website at www.abpn.com .
    [Show full text]
  • The Vagus Nerve Can Predict and Possibly Modulate Non- Communicable Chronic Diseases: Introducing a Neuroimmunological Paradigm to Public Health
    12/17/19, 08:13 Page 1 of 15 J Clin Med. 2018 Oct; 7(10): 371. PMCID: PMC6210465 Published online 2018 Oct 19. doi: 10.3390/jcm7100371 PMID: 30347734 The Vagus Nerve Can Predict and Possibly Modulate Non- Communicable Chronic Diseases: Introducing a Neuroimmunological Paradigm to Public Health Yori Gidron,1,* Reginald Deschepper,2 Marijke De Couck,2,3 Julian F. Thayer,4 and Brigitte Velkeniers5 1SCALAB UMR CNRS 9193, Université Lille, BP 60149, Villeneuve d’Ascq CEDEX 59653, France 2Mental Health and Wellbeing Research Group, Vrije Universiteit Brussel (VUB), Laerbeeklaan 103, 1090 Jette, Brussels, Belgium; [email protected] (R.D.); [email protected] (M.D.C.) 3Faculty of Health Care, University College Odisee, 9302 Aalst, Belgium 4Department of Neuroscience and Psychology, College of Medicine, Ohio State University, 33 Psychology Building, 1835 Neil Ave. Columbus, OH 43210, USA; [email protected] 5Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Laerbeeklaan 103, 1090 Jette, Brussels, Belgium; [email protected] *Correspondence: [email protected]; Tel.: +32-498-56-82-77 Received 2018 Sep 19; Accepted 2018 Oct 15. Copyright © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Global burden of diseases (GBD) includes non-communicable conditions such as cardiovascular diseases, cancer and chronic obstructive pulmonary disease. These share important behavioral risk factors (e.g., smoking, diet) and pathophysiological contributing factors (oxidative stress, inflammation and excessive sympathetic activity).
    [Show full text]
  • PROGRESS in NEUROSCIENCE PINS “CNS Lymphatic Drainage In
    PROGRESS IN NEUROSCIENCE PINS Seminar Series of the Brain & Mind Research Institute Weill Cornell Medical College (WCMC) & The Graduate Program in Neuroscience of WCMC and Sloan Kettering Institute Thursday, 12/8/16, 4 PM, coffee at 3:45 PM Uris Auditorium “CNS lymphatic drainage in health and disease” Jonathan Kipnis, Ph.D., Center for Brain Immunology and Glia (BIG), Harrison Distinguished Teaching Professor of Neuroscience and Chair, Department of Neuroscience, University of Virginia Abstract The central nervous system was considered to be devoid of classical lymphatic drainage. We recently challenged that paradigm by demonstrating the presence of a lymphatic vasculature in the surrounding of the brain called the meninges. We demonstrated that lymphatic vessels, expressing the markers for lymphatic endothelial cells (LEC; i.e Lyve-1, Prox1, podoplanin, VEGFR3 and CCL21) are located along the dural sinuses. They present features of initial lymphatics, and, importantly, drain fluids, macromolecules and immune cells from the cerebrospinal fluid and the CNS parenchyma into the deep cervical lymph nodes. Our recent efforts are concentrated on understanding the role of meningeal lymphatic vessels in CNS function in health and disease. Our results suggest that the drainage into the deep cervical lymph nodes might play different roles at different stages of several neurological diseases. Understanding the function of the lymphatic drainage in CNS might shed a new light on neurological disorders and offer new therapeutic targets. Recent Relevant Publications: 1. Gadani SP, Walsh JT, Smirnov I, Zheng J and Kipnis J. (2015) The glia-derived alarmin IL-33 orchestrates the post CNS injury immune response and promotes recovery.
    [Show full text]
  • Quarterly Report: Second Quarter 2017
    QUARTERLY REPORT: 2ND QUARTER 2017 Q2 2017 Research Consortium Welcomes Three New Members The Brain’s 2 Phyllis Rappaport Updates Former College Classmates Lymphatic System 3 Modern science has an incredibly thorough understanding of the human body. It is J. McLaughlin’s ‘Sip ’n Shop’ hard to imagine that any organ or system could exist within the body that has yet to be Fundraiser discovered. Yet this is exactly what happened in 2015, when researchers discovered 4 lymphatic vessels around and within the brain. Living with Alzheimer’s Film The lymphatic system exists throughout the body. Part of the immune system, it consists Screening of a network of channels (vessels) and glands called “nodes.” Nodes create immune cells 5 to help the body fight infection. The vessels carry fluid containing these immune cells, as well as pathogens and harmful cellular waste products, away from organs. Until recently, CaringKind Alliance Update lymphatic vessels had never been observed in or around the brain. While there were other 5 known ways—such as immune cells called macrophages—for waste products to be Extra Sets of Hands cleared from the brain, researchers had trouble explaining the volume of clearance they observed without a lymphatic system. 5 Cure Alzheimer’s Fund A recent study at the University of Virginia by Jonathan Kipnis, Ph.D., and his colleagues Heroes Antoine Louveau, Ph.D., and Tajie Harris, Ph.D., shed new light on this problem. Using a new method of examining the meninges, a membrane that covers the brain, they 6 discovered there was in fact a network of lymphatic vessels surrounding the brain.
    [Show full text]
  • A Strategic Investment in Pediatrics and Infectious Diseases Dr
    December 2020 milestones Dr. Sallie Permar, the new chair of Weill Cornell Medicine’s Department of Pediatrics A Strategic Investment in Pediatrics and Infectious Diseases Dr. Sallie Permar, a distinguished physician-scientist who of such viruses as HIV, Zika and cytomegalovirus (CMV), the specializes in pediatric infectious diseases, joined Weill Cornell most common congenital infection and a leading cause of birth Medicine on December 1 as the new chair of the Department defects. In her research, she also discovered a protein in breast of Pediatrics. milk that neutralizes HIV, the virus that causes AIDS. The recruitment of Dr. Permar is part of Weill Cornell Medicine’s “Dr. Permar will enhance our mission in both pediatrics and strategic investment in pediatrics and infectious disease research infectious diseases, building on our wealth of research as she and clinical care, with a goal of raising nearly $60 million to support collaborates with investigators and clinicians to improve the expanded translational research efforts in the Belfer Research lives of children,” says Dr. Augustine M.K. Choi, the Stephen and Building. The COVID-19 pandemic has reinforced the growing need Suzanne Weiss Dean. “As a leading academic medical center, for research of infectious diseases of all types – including areas in we must expand our investment in infectious diseases with an which Dr. Permar specializes. She and her team are working on the eye toward future global pathogens that can have a profound development of vaccines to prevent mother-to-child transmission impact on human health.” continued on page 2 A Strategic Investment in Pediatrics and Infectious Diseases continued from cover Infectious disease experts at Well Cornell Medicine more than $3 million to establish the Gerald M.
    [Show full text]
  • 2018 Winter Newsletter
    Holiday Gift Ideas A Q&A wth Alan Arnette Plan Your Giving Now Celebrate the reason for the season Arnette is a mountaineer, speaker Make giving a commitment with a gift that gives back and Alzheimer’s advocate to Cure Alzheimer's Fund WINTER SEASON 2018 THE CASE FOR HOPE Panel Explores the Path Forward in Alzheimer’s Research at Our 8th Annual Scientific Symposium THE CASE FOR HOPE SCIENCE PANEL EXPLORES THE PATH FORWARD IN ALZHEIMER’S RESEARCH The 8th Annual Cure Alzheimer’s Fund Symposium featured award-winning NPR science writer Jon Hamilton moderating a discussion between Drs. Ron Petersen, Bob Vassar and Teresa Gomez-Isla on the Case For Hope in Alzheimer’s disease research. Co-Chairman Jeff Morby started the meeting by announcing that for the frst time. She remembered being impacted by learning Cure Alzheimer’s Fund had just received the designation of Top that the disease can steal one of the “greatest treasures we have 10 Best Medical Research Organizations by nonproft watchdog as human beings—our memories.” Charity Navigator. After providing the audience with an update of CureAlz's results, including $75 million distributed for 340 Progressing Through Challenges research grants to 127 of the world’s leading researchers, he then introduced Dr. Rudy Tanzi, who introduced the panel: Dr. Petersen The panelists described the challenge of connecting the events as a champion for scientists whose policy work has been pav- happening in the brain to the symptoms experienced by patients. ing the way for clinical trials that target amyloid before the onset All three of the scientists explained that amyloid plaques and of symptoms, Dr.
    [Show full text]
  • 2020 Annual Report Our Mission
    2020 ANNUAL REPORT OUR MISSION Cure Alzheimer’s Fund is a nonprofit organization dedicated to funding research with the highest probability of preventing, slowing or reversing Alzheimer’s disease. Annual Report 2020 MESSAGE FROM THE CHAIRMEN 2 THE MAIN ELEMENTS OF THE PATHOLOGY OF ALZHEIMER’S DISEASE 9 RESEARCH AREAS OF FOCUS 10 PUBLISHED PAPERS 12 CURE ALZHEIMER’S FUND CONSORTIA 20 OUR RESEARCHERS 22 2020 FUNDED RESEARCH 32 2020 EVENTS TO FACILITATE RESEARCH COLLABORATION 68 MESSAGE FROM THE PRESIDENT 70 2020 FUNDRAISING 72 2020 FINANCIALS 73 OUR PEOPLE 74 OUR HEROES 75 AWARENESS 78 IN MEMORY AND IN HONOR 80 SUPPORT OUR RESEARCH 81 Message From The Chairmen Dear Friends, 2020 was a truly remarkable year: • Despite the COVID-19 pandemic, we were fully functional with all of our wonderful staff working from their homes. We were able to pay and retain all of our employees, thanks to the generosity of our directors. • And, amazingly, we were able to increase our fundraising by 2%, in this very tough year, to $25.9 million provided by 21,000 donors. • The above enabled us to fund 59 research grants totaling $16.5 million. We have, since inception, financed 525 grants, representing $125 million in cumulative funding through March 2021. • We have one therapy well on its way through clinical trials, and another expected to enter clinical trials in late 2021 or 2022. Our Scientists Approximately 175 scientists affiliated with 75 institutions around the world are working on our projects. They are profiled in the pages that follow. Many labs faced funding challenges during COVID-19, and our consistent support was very beneficial for ensuring that vital staff could be retained and scientific progress was preserved.
    [Show full text]
  • University of Copenhagen, Copenhagen, Denmark
    Understanding the functions and relationships of the glymphatic system and meningeal lymphatics Louveau, Antoine; Plog, Benjamin A.; Antila, Salli; Alitalo, Kari; Nedergaard, Maiken; Kipnis, Jonathan Published in: The Journal of Clinical Investigation DOI: 10.1172/JCI90603 Publication date: 2017 Document version Publisher's PDF, also known as Version of record Document license: Unspecified Citation for published version (APA): Louveau, A., Plog, B. A., Antila, S., Alitalo, K., Nedergaard, M., & Kipnis, J. (2017). Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. The Journal of Clinical Investigation, 127(9), 3210-3219. https://doi.org/10.1172/JCI90603 Download date: 26. Sep. 2021 Understanding the functions and relationships of the glymphatic system and meningeal lymphatics Antoine Louveau, … , Maiken Nedergaard, Jonathan Kipnis J Clin Invest. 2017;127(9):3210-3219. https://doi.org/10.1172/JCI90603. Review Series Recent discoveries of the glymphatic system and of meningeal lymphatic vessels have generated a lot of excitement, along with some degree of skepticism. Here, we summarize the state of the field and point out the gaps of knowledge that should be filled through further research. We discuss the glymphatic system as a system that allows CNS perfusion by the cerebrospinal fluid (CSF) and interstitial fluid (ISF). We also describe the recently characterized meningeal lymphatic vessels and their role in drainage of the brain ISF, CSF, CNS-derived molecules, and immune cells from the CNS and meninges to the peripheral (CNS-draining) lymph nodes. We speculate on the relationship between the two systems and their malfunction that may underlie some neurological diseases. Although much remains to be investigated, these new discoveries have changed our understanding of mechanisms underlying CNS immune privilege and CNS drainage.
    [Show full text]
  • Bone Marrow Transplant Alleviates Rett Symptoms in Mice
    Spectrum | Autism Research News https://www.spectrumnews.org NEWS Bone marrow transplant alleviates Rett symptoms in mice BY EMILY SINGER 19 MARCH 2012 Managing microglia: Mutant mice lacking the MeCP2 protein are small (left), while those bred to have a normal version of the MeCP2 protein in their myeloid cells ? precursors to microglia ? grow to normal size (right). A bone marrow transplant from healthy mice to those lacking the MeCP2 protein, which causes Rett syndrome in humans when mutated, extends lifespan and alleviates symptoms of the disorder, according to research published online 18 March in Nature1. Researchers found that microglia, which take root in the brain after the transplant, are the most important component of the treatment. These cells are known to act as scavengers that clean up cellular debris, but recent research suggests they also have other roles, including influencing neural transmission and development of the synapse, the junction between neurons. Rett syndrome is a rare disorder caused by deletion or mutation of the X-linked MeCP2 gene and occurs almost exclusively in females. Symptoms emerge around 6 to 18 months of age and include breathing problems, intellectual disability, seizures, language deficits and other autism-like impairments. Mice in which the MeCP2 gene has been knocked out in all or a subset of cells mimic many of the features of Rett syndrome. 1 / 4 Spectrum | Autism Research News https://www.spectrumnews.org Following treatment, abnormal breathing patterns and apnea, a temporary interruption in breathing seen in both MeCP2 knockout mice and children with Rett syndrome, are diminished in the knockout animals.
    [Show full text]
  • Neuroscience: the Science of the Brain
    NEUROSCIENCE SCIENCE OF THE BRAIN AN INTRODUCTION FOR YOUNG STUDENTS British Neuroscience Association European Dana Alliance for the Brain Neuroscience: the Science of the Brain 1 The Nervous System P2 2 Neurons and the Action Potential P4 3 Chemical Messengers P7 4 Drugs and the Brain P9 5 Touch and Pain P11 6 Vision P14 Inside our heads, weighing about 1.5 kg, is an astonishing living organ consisting of 7 Movement P19 billions of tiny cells. It enables us to sense the world around us, to think and to talk. The human brain is the most complex organ of the body, and arguably the most 8 The Developing P22 complex thing on earth. This booklet is an introduction for young students. Nervous System In this booklet, we describe what we know about how the brain works and how much 9 Dyslexia P25 there still is to learn. Its study involves scientists and medical doctors from many disciplines, ranging from molecular biology through to experimental psychology, as well as the disciplines of anatomy, physiology and pharmacology. Their shared 10 Plasticity P27 interest has led to a new discipline called neuroscience - the science of the brain. 11 Learning and Memory P30 The brain described in our booklet can do a lot but not everything. It has nerve cells - its building blocks - and these are connected together in networks. These 12 Stress P35 networks are in a constant state of electrical and chemical activity. The brain we describe can see and feel. It can sense pain and its chemical tricks help control the uncomfortable effects of pain.
    [Show full text]
  • Human and Nonhuman Primate Meninges Harbor Lymphatic Vessels
    SHORT REPORT Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI Martina Absinta1†, Seung-Kwon Ha1†, Govind Nair1, Pascal Sati1, Nicholas J Luciano1, Maryknoll Palisoc2, Antoine Louveau3, Kareem A Zaghloul4, Stefania Pittaluga2, Jonathan Kipnis3, Daniel S Reich1* 1Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States; 2Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, United States; 3Center for Brain Immunology and Glia, Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, United States; 4Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States Abstract Here, we report the existence of meningeal lymphatic vessels in human and nonhuman primates (common marmoset monkeys) and the feasibility of noninvasively imaging and mapping them in vivo with high-resolution, clinical MRI. On T2-FLAIR and T1-weighted black-blood imaging, lymphatic vessels enhance with gadobutrol, a gadolinium-based contrast agent with high propensity to extravasate across a permeable capillary endothelial barrier, but not with gadofosveset, a blood-pool contrast agent. The topography of these vessels, running alongside dural venous sinuses, recapitulates the meningeal lymphatic system of rodents. In primates, *For correspondence: meningeal
    [Show full text]